Search - tctmd.com

Displaying 381 - 400 of 602

Sort: Relevancy | Date

Update From the Clinical Trials and Where I Would and Wouldn’t Use It

Presentation TVT 2023

Update From the Clinical Trials and Where I Would and Wouldn’t Use It

Presenter: Basel Ramlawi

June 08, 2023

Update From the Clinical Trials and Where I Would and Wouldn’t Use It

Presentation TVT 2023

Update From the Clinical Trials and Where I Would and Wouldn’t Use It

Presenter: Azeem Latib

June 08, 2023

Etiologies of Exclusion Rates for Transcatheter Mitral and Tricuspid Valve Structural Heart Clinical Trials at a High volume Quaternary Care Hospital

Presentation TVT 2023

Etiologies of Exclusion Rates for Transcatheter Mitral and Tricuspid Valve Structural Heart Clinical Trials at a High volume Quaternary Care Hospital

Presenter: Lu Chen

June 08, 2023

Lessons Learned from the PROTECTED TAVR Trial: Mapping the Future of Cerebral Embolic Protection

Presentation TVT 2023

Lessons Learned from the PROTECTED TAVR Trial: Mapping the Future of Cerebral Embolic Protection

Presenter: Samir Kapadia

June 08, 2023

VitaFlow System: The SEASON-AR Trial

Presentation TVT 2023

VitaFlow System: The SEASON-AR Trial

Presenter: Junjie Zhang

June 08, 2023

InterShunt: EASE-HF Trial Results

Presentation TVT 2023

InterShunt: EASE-HF Trial Results

Presenter: Robin Germany

June 08, 2023

What Works, What’s Noise? Novel Approaches Offer Hope in CLTI

News Conference News LINC 2023

What Works, What’s Noise? Novel Approaches Offer Hope in CLTI

June 07, 2023

Good Real-World Outcomes Seen With Next-Generation Carotid Stent

News Conference News LINC 2023

Good Real-World Outcomes Seen With Next-Generation Carotid Stent

June 06, 2023

CABG and PCI Comparable in ACS Patients With Left Main CAD

News Daily News

CABG and PCI Comparable in ACS Patients With Left Main CAD

Michael O'Riordan

June 06, 2023

FDA Grants First HF Indication for IV Iron to Ferric Carboxymaltose

News Daily News

FDA Grants First HF Indication for IV Iron to Ferric Carboxymaltose

June 05, 2023

Andexanet Alfa, Reversal Agent for Factor Xa Inhibitors, Boosts Hemostasis

News Daily News

Andexanet Alfa, Reversal Agent for Factor Xa Inhibitors, Boosts Hemostasis

June 05, 2023

Ticagrelor May Be an Option for Averting Brain Lesions During Carotid Stenting

News Conference News ESOC 2023

Ticagrelor May Be an Option for Averting Brain Lesions During Carotid Stenting

June 02, 2023

June 2023 News Roundup

News Opinion CV Team Dispatch

June 2023 News Roundup

June 01, 2023

TESLA Falls Short, but Experts Still See Role for EVT in Large-Core Strokes

News Conference News ESOC 2023

TESLA Falls Short, but Experts Still See Role for EVT in Large-Core Strokes

May 31, 2023

TCTMD’s Top 10 Most Popular Stories for May 2023

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for May 2023

May 31, 2023

SPIRIT 48: Long DES for Diffuse CAD Highly Deliverable, Safe at 1 Year

News Conference News SCAI 2023

SPIRIT 48: Long DES for Diffuse CAD Highly Deliverable, Safe at 1 Year

May 31, 2023

LBB Area Pacing Outperforms Biventricular in CRT: Large, Observational Study

News Conference News HRS 2023

LBB Area Pacing Outperforms Biventricular in CRT: Large, Observational Study

May 30, 2023

With New LDL Goalposts in FH, Combo Therapy Must Start Early

News Conference News EAS 2023

With New LDL Goalposts in FH, Combo Therapy Must Start Early

Michael O'Riordan

May 29, 2023

Surgery and ‘Care-Bundle’ Trials Raise Hopes for ICH Care

News Conference News ESOC 2023

Surgery and ‘Care-Bundle’ Trials Raise Hopes for ICH Care

May 26, 2023

Could Copper Chelation Benefit HFrEF? TRACER-HF Offers Mixed Clues

News Conference News ESC Heart Failure 2023

Could Copper Chelation Benefit HFrEF? TRACER-HF Offers Mixed Clues

May 25, 2023

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.